{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:08:38Z","timestamp":1790752118945,"version":"4.1.0"},"reference-count":62,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"DOI":"10.1210\/jc.2007-0364","type":"journal-article","created":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T18:34:06Z","timestamp":1179945246000},"page":"3089-3094","source":"Crossref","is-referenced-by-count":23,"title":["Hormonal and Nutritional Effects on Cardiovascular Risk Markers in Young Women"],"prefix":"10.1210","volume":"92","author":[{"given":"Elizabeth A.","family":"Lawson","sequence":"first","affiliation":[{"name":"Department of Neuroendocrine Unit (E.A.L., K.K.M., V.A.M., M.M., E.M., A.K.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Neuroendocrine Unit (E.A.L., K.K.M., V.A.M., M.M., E.M., A.K.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vani A.","family":"Mathur","sequence":"additional","affiliation":[{"name":"Department of Neuroendocrine Unit (E.A.L., K.K.M., V.A.M., M.M., E.M., A.K.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusmita","family":"Misra","sequence":"additional","affiliation":[{"name":"Department of Neuroendocrine Unit (E.A.L., K.K.M., V.A.M., M.M., E.M., A.K.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erinne","family":"Meenaghan","sequence":"additional","affiliation":[{"name":"Department of Neuroendocrine Unit (E.A.L., K.K.M., V.A.M., M.M., E.M., A.K.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Herzog","sequence":"additional","affiliation":[{"name":"Department of Harris Center, Department of Psychiatry (D.B.H.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Klibanski","sequence":"additional","affiliation":[{"name":"Department of Neuroendocrine Unit (E.A.L., K.K.M., V.A.M., M.M., E.M., A.K.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114100841800_R1","first-page":"727","article-title":"Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study.","volume-title":"JAMA","author":"Strong","year":"1999"},{"key":"key\n\t\t\t\t2019041114100841800_R2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0015-0282(16)58321-6","article-title":"Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis.","volume":"65","author":"Lobo","year":"1996","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114100841800_R3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","article-title":"Estrogen regulation of growth hormone action.","volume":"25","author":"Leung","year":"2004","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114100841800_R4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency.","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041114100841800_R5","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1210\/jcem.87.4.8364","article-title":"Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.","volume":"87","author":"Sesmilo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R6","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1210\/jcem.86.12.8087","article-title":"Inflammatory cardiovascular risk markers in women with hypopituitarism.","volume":"86","author":"Sesmilo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0021-9150(03)00235-1","article-title":"C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.","volume":"170","author":"Heald","year":"2003","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041114100841800_R8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archpsyc.60.2.179","article-title":"Predictors of mortality in eating disorders.","volume":"60","author":"Keel","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t2019041114100841800_R9","first-page":"762","article-title":"The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins.","volume":"75","author":"Counts","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2796.2005.01563.x","article-title":"Distribution and determinants of serum high-sensitivity C-reactive protein in a population of young adults: the Cardiovascular Risk in Young Finns Study.","volume":"258","author":"Raitakari","year":"2005","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t2019041114100841800_R11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.ijo.0802713","article-title":"Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults.","volume":"28","author":"Williams","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key\n\t\t\t\t2019041114100841800_R12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.ATV.21.6.968","article-title":"Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women.","volume":"21","author":"Heilbronn","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019041114100841800_R13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/hc0502.103331","article-title":"Weight loss reduces C-reactive protein levels in obese postmenopausal women.","volume":"105","author":"Tchernof","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114100841800_R14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1079\/BJN20041151","article-title":"Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia.","volume":"91","author":"Weinbrenner","year":"2004","journal-title":"Br J Nutr"},{"key":"key\n\t\t\t\t2019041114100841800_R15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1098-108X(199903)25:2<187::AID-EAT8>3.0.CO;2-9","article-title":"Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic.","volume":"25","author":"Case","year":"1999","journal-title":"Int J Eat Disord"},{"key":"key\n\t\t\t\t2019041114100841800_R16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1098-108X(199809)24:2<217::AID-EAT11>3.0.CO;2-W","article-title":"Lipid levels in anorexia nervosa.","volume":"24","author":"Mehler","year":"1998","journal-title":"Int J Eat Disord"},{"key":"key\n\t\t\t\t2019041114100841800_R17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0197-0070(90)90348-6","article-title":"Effect of weight restoration on the dyslipoproteinemia of anorexia nervosa.","volume":"11","author":"Arden","year":"1990","journal-title":"J Adolesc Health Care"},{"key":"key\n\t\t\t\t2019041114100841800_R18","first-page":"1283","article-title":"Cholesterol concentrations in patients with anorexia nervosa and in healthy controls.","volume":"11","author":"Matzkin","year":"2006","journal-title":"Int J Psychiatr Nurs Res"},{"key":"key\n\t\t\t\t2019041114100841800_R19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/eat.20298","article-title":"Etiology of hypercholesterolemia in patients with anorexia nervosa.","volume":"39","author":"Ohwada","year":"2006","journal-title":"Int J Eat Disord"},{"key":"key\n\t\t\t\t2019041114100841800_R20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2265.2003.01702.x","article-title":"Hyperadiponectinaemia in anorexia nervosa.","volume":"58","author":"Delporte","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114100841800_R21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0009-8981(99)00256-9","article-title":"Plasma cholesterol and endogenous cholesterol synthesis during refeeding in anorexia nervosa.","volume":"294","author":"Feillet","year":"2000","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t2019041114100841800_R22","author":"Diagnostic and statistical manual of mental disorders,","year":"2000","edition":"4th ed."},{"key":"key\n\t\t\t\t2019041114100841800_R23","first-page":"2049","article-title":"Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea.","volume":"84","author":"Grinspoon","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7326\/0003-4819-133-10-200011210-00011","article-title":"Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa.","volume":"133","author":"Grinspoon","year":"2000","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041114100841800_R25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archinte.165.5.561","article-title":"Medical findings in outpatients with anorexia nervosa.","volume":"165","author":"Miller","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041114100841800_R26","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1210\/jc.2004-0720","article-title":"Preservation of neuroendocrine control of reproductive function despite severe undernutrition.","volume":"89","author":"Miller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R27","first-page":"2309","article-title":"Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake.","volume":"83","author":"Miller","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/oxfordjournals.aje.a114915","article-title":"A mail survey of physical activity habits as related to measured physical fitness.","volume":"127","author":"Kohl","year":"1988","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t2019041114100841800_R29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041114100841800_R30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114100841800_R31","first-page":"3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health.","volume-title":"Circulation","author":"Expert Panel of the National Cholesterol Education Program","year":"2002"},{"key":"key\n\t\t\t\t2019041114100841800_R32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1054-139X(99)00121-4","article-title":"Use of hormone replacement therapy to reduce the risk of osteopenia in adolescent girls with anorexia nervosa.","volume":"26","author":"Robinson","year":"2000","journal-title":"J Adolesc Health"},{"key":"key\n\t\t\t\t2019041114100841800_R33","first-page":"898","article-title":"The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa.","volume":"80","author":"Klibanski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R34","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/jcem.87.6.8574","article-title":"Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa.","volume":"87","author":"Grinspoon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1083-3188(02)00145-6","article-title":"The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa.","volume":"15","author":"Golden","year":"2002","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"key\n\t\t\t\t2019041114100841800_R36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/eje.0.1460045","article-title":"The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa.","volume":"146","author":"Munoz","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114100841800_R37","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis.","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114100841800_R38","first-page":"321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial.","volume-title":"JAMA","author":"Writing Group for the Women\u2019s Health Initiative Investigators","year":"2002"},{"key":"key\n\t\t\t\t2019041114100841800_R39","first-page":"605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.","volume-title":"JAMA","author":"Hulley","year":"1998"},{"key":"key\n\t\t\t\t2019041114100841800_R40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.maturitas.2004.02.016","article-title":"Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.","volume":"49","author":"Rossi","year":"2004","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t2019041114100841800_R41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2005.06.011","article-title":"The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: The postmenopausal estrogen progestin intervention (PEPI) trial.","volume":"185","author":"Hu","year":"2006","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041114100841800_R42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114100841800_R43","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels.","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114100841800_R44","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114100841800_R45","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114100841800_R46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041114100841800_R47","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000017493.03108.1C","article-title":"Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death.","volume":"105","author":"Albert","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114100841800_R48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/(SICI)1098-108X(200007)28:1<20::AID-EAT3>3.0.CO;2-X","article-title":"Mortality in eating disorders: a descriptive study.","volume":"28","author":"Herzog","year":"2000","journal-title":"Int J Eat Disord"},{"key":"key\n\t\t\t\t2019041114100841800_R49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.ejcn.1602491","article-title":"Long-term mortality in anorexia nervosa: a report after an 8-year follow-up and a review of the most recent literature.","volume":"61","author":"Signorini","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"key\n\t\t\t\t2019041114100841800_R50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4065\/78.3.278","article-title":"Long-term survival of patients with anorexia nervosa: a population-based study in Rochester, Minn.","volume":"78","author":"Korndorfer","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019041114100841800_R51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1176\/ajp.152.7.1073","article-title":"Mortality in anorexia nervosa.","volume":"152","author":"Sullivan","year":"1995","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019041114100841800_R52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3999(97)00267-5","article-title":"Standardized mortality in eating disorders: a quantitative summary of previously published and new evidence.","volume":"44","author":"Nielsen","year":"1998","journal-title":"J Psychosom Res"},{"key":"key\n\t\t\t\t2019041114100841800_R53","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis From the Women\u2019s Health Initiative observational study.","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114100841800_R54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","article-title":"The effect of including C-reactive protein in cardiovascular risk prediction models for women.","volume":"145","author":"Cook","year":"2006","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041114100841800_R55","first-page":"1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial.","volume-title":"JAMA","author":"The Women\u2019s Health Initiative Steering Committee","year":"2004"},{"key":"key\n\t\t\t\t2019041114100841800_R56","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.amjmed.2005.08.012","article-title":"Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.","volume":"119","author":"Reuben","year":"2006","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041114100841800_R57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.maturitas.2005.01.004","article-title":"The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.","volume":"52","author":"Eilertsen","year":"2005","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t2019041114100841800_R58","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ahj.2004.11.025","article-title":"Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.","volume":"150","author":"Lakoski","year":"2005","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2019041114100841800_R59","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.gme.0000172267.24949.70","article-title":"Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.","volume":"12","author":"Vitale","year":"2005","journal-title":"Menopause"},{"key":"key\n\t\t\t\t2019041114100841800_R60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1479-828X.2004.00183.x","article-title":"Effects of oestrogen replacement therapy on serum C-reactive protein levels in hysterectomised women.","volume":"44","author":"Kiran","year":"2004","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"key\n\t\t\t\t2019041114100841800_R61","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0735-1097(03)00156-6","article-title":"Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women.","volume":"41","author":"Vongpatanasin","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041114100841800_R62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/07853890310007090","article-title":"Markers of inflammation in women on different hormone replacement therapies.","volume":"35","author":"Frohlich","year":"2003","journal-title":"Ann Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/8\/3089\/10406003\/jcem3089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T07:51:33Z","timestamp":1587541893000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/8\/3089\/2597929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-0364","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}